慢性腎臟病與失智症之探討

Discussion on Chronic Kidney Disease and Dementia

10.6647/CN.202209_29(3).0003

楊舒雅(Shu-Ya Yang)

認知功能障礙 ； 失智症 ； 透析 ； 慢性腎臟病 ； 紅血球生成素 ； 失智症照護 ； Cognitive Impairment ； Dementia ； Dialysis ； Chronic Kidney Disease ； EPO ； Dementia Care

彰化護理

29卷3期（2022 / 09 / 01）

9 - 14

繁體中文

失智症（dementia）為當前重要的醫療議題，多種致病因子已逐漸被證實，其中慢性腎臟病（chronic kidney disease）是已知會增加罹患失智症的危險因子，慢性腎臟病可透過血管傷害、內皮細胞功能障礙及尿毒素的影響而造成認知功能障礙，最終進展成失智症，嚴重影響病人的自身安全、影響末期腎臟病的治療（如配合透析、正確服藥）。失智者的照護不是僅聚焦於其本人，其周邊的環境、照顧者、醫療團隊等皆應被視為一個治療聯盟，失智者與照顧者的信任感與安全感是影響照護品質的重要因素。本篇文章將針對失智症的定義、種類、診斷、慢性腎臟病患者罹患失智症危險因子、注射紅血球生成素及鐵劑與失智症之關聯、透析患者罹患失智症盛行率、後續治療照護及照護者喘息做探討，希望藉由此篇文章提供照護者參考。

Dementia is an important medical issue at present, and a variety of pathogenic factors have been gradually confirmed. Among them, chronic kidney disease is known to increase the risk of dementia. Chronic kidney disease can cause cognitive dysfunction through vascular damage, endothelial cell dysfunction and the influence of urinary toxins, and eventually progress to dementia, which may seriously affect the patient's safety and the treatment of end-stage renal disease (such as cooperating with dialysis and take the medication correctly ). The care of people with dementia should not only focus on themselves. The treatment plan should include environmental factors, and the multidisciplinary team should include caregiver. Trust between people with dementia and caregivers and the sense of security is an important factor affecting the quality of care. This article will discuss the definition, types and diagnosis of dementia, risk factors for dementia in patients with chronic kidney disease, the association of erythropoietin and iron injections with dementia, the prevalence of dementia in dialysis patients, follow-up care and Respite Care Service . We hope this article will serve as a reference for the caregiver.

1. Cheng, K.C.,Chen, Y.L.,Lai, S.W.,Mou, C.H.,Tsai, P.Y.,Sung, F.(2012).Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan.BMC Nephrol,13,129.
2. Helmer, C.,Stengel, B.,Metzger, M.,Froissart, M.,Massy, Z.A.,Tzourio, C.,Berr, C.,Dartigues, J.F.(2011).Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study.Neurology,77(23),2043-2051.
3. Hung, P.H.,Yeh, C.C.,Hsiao, C,Y,Sung, P.S.,Muo, C.H.,Sung, F.C.,Hung, k.u.,Tsai, k.j.(2017).End stage renal disease is associated with development of dementia.Oncotarget,8(64),107348-107355.
4. Hung, P.H.,Yeh, C.C.,Sung, F.C.,Muo, C.H.,Muo, C.H.,Hung, K.Y.,Tsai, K.J.(2019).Erythropoietin prevents dementia in hemodialysis patients : a nationwide population-based study.Aging,11(17),6941-6950.
5. Kalaria, R.N.(2018).The pathology and pathophysiology of vascular dementia.Neuropharmacology,134(Pt B),226-239.
6. Kuo, Y.T.,Li, C.Y.,Sung, J.M.,Chang, C.C.,Wang, J.D.,Sun, C.Y.,Wu, J.L.,Chang, Y.T.(2019).Risk of dementia in patients with end-stage renal disease under maintenance dialysisa nationwide population-based study with consideration of competing risk of mortality.Alzheimers Res Ther,11(1),31.
7. Shea, Y.F.,Lee, M.C.,Mok, M.M.,Chan, F.H.,Chan, T.M.(2019).Prevalence of cognitive impairment among peritoneal dialysis patients: a systematic review and meta-analysis.Clin Exp Nephrol,23(10),1221-1234.
8. Tamura, M.K.,Yaffe, K.(2011).Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies.Kidney Int,79(1),14-22.
9. Viggiano, D.,Wagner, C.A.,Blankestijn, P.J.,Bruchfeld, A.,Fliser, D.,Fouque , D.,Frische ,S.,Gesualdo, L.,Gutiérrez, E.,Goumenos, D.,Hoorn, E.J.,Eckardt, K.U.,Knauß,S.,König, M.,Malyszko, J.,Massy, Z.,Nitsch, D.,Pesce, F.,Rychlík, I.,Capasso, G.(2019).Mild cognitive impairment and kidney disease: clinical aspects.Nephrol Dial Transplant,35(1),10-17.
10. Weintraub, J.(2018).Dementia in dialysis: an eye on best practices.Clin J Am Sco Nephrol,13(9),1305-1306.
11. Zhang, Y.H.,Yang, Z.K.,Wang, J.W.,Xiong, Z.Y.,Liao, j.L.,Hao, L.,Liu, G.L.,Ren, Y.P.,Wang, Q.,Duan, L.P.,Zheng, Z.X.,Dong, J.(2018).Cognitive Changes in Peritoneal Dialysis Patients: A Multicenter Prospective Cohort Study.Am J Kidney Dis,72(5),691-700.
12. Zwieten, A.V.,Wong, G.,Ruospo, M.,Palmer, S.C.,Barulli.M.R.,Iurillo, A.,Saglimbene, V.,Natale, P.,Gargano, L.,Murgo, M.,Loy, C.T.,Tortelli, R.,Craig, J.C.,Johnson, D.W.,Tonelli, M.,Hegbrant, J.,Wollheim, C.,Logroscin, G.,Strippo li, G.F.(2018).Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study.Nephrol Dial Transplant,33(7),1197-1206.
13. 林宛玲,呂宜峰,劉建良,翁林仲,楊啟正(2020)。失智症照護之五大重要發展方向。北市醫學雜誌，17(2)，163-173。
14. 凌采絜,張育誌(2021)。末期腎臟病與慢性認知障礙之文獻回顧。內科學誌，32(1)，20-26。
15. 張家榮,蘇裕翔,陳宗賢,蔡坤哲,洪培豪(2021)。慢性腎臟病與失智症之回顧。北市醫學雜誌，18(4)，363-373。
16. 衛生福利部(2022年6月7日) ‧失智症防治照護政策綱領暨行動方案2.0（含工作項目）。https://1966.gov.tw/LTC/cp-4020-42469-201.html